Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder - Trial NCT06375525
Access comprehensive clinical trial information for NCT06375525 through Pure Global AI's free database. This phase not specified trial is sponsored by Prof. Doron Gothelf MD and is currently Completed. The study focuses on Children Aged 6-18 Years With the Diagnosis of ADHD. Target enrollment is 39 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Janssen's icon Application (App)
Interventional
device
Sponsor & Location
Prof. Doron Gothelf MD
Sheba Medical Center
Timeline & Enrollment
N/A
Nov 01, 2015
Aug 01, 2017
Primary Outcome
Attention Module of the Kiddie-SADS questionniare
Summary
The overarching aim of the study is to assess the efficacy of Janssen's icon Application
 (App), a digital tool designed to improve adherence to medication treatment in children with
 ADHD.
 
 Our specific hypotheses are:
 
 1. In children receiving medication for ADHD those provided with the App tool will be more
 adherent to treatment than children treated as usual (i.e., not provided with the App
 tool).
 
 2. Adherent patients will show greater improvement of ADHD symptoms and related
 dysfunction.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06375525
Device Trial